Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Wirshing, Donna A.
Erhart, Steven M.
Pierre, Joseph M.
and
Boyd, Jennifer A.
2000.
Nonextrapyramidal side effects of novel antipsychotics.
Current Opinion in Psychiatry,
Vol. 13,
Issue. 1,
p.
45.
MASAND, PRAKASH S.
and
GUPTA, SANJAY
2000.
Long-Term Adverse Effects of Novel Antipsychotics.
Journal of Psychiatric Practice,
Vol. 6,
Issue. 6,
p.
299.
Popkin, Michael K.
and
Colon, Eduardo A.
2001.
The interface of psychiatric disorders and diabetes mellitus.
Current Psychiatry Reports,
Vol. 3,
Issue. 3,
p.
243.
Koller, Elizabeth
Schneider, Bruce
Bennett, Katherine
and
Dubitsky, Greg
2001.
Clozapine-associated diabetes.
The American Journal of Medicine,
Vol. 111,
Issue. 9,
p.
716.
Liebzeit, Krystal A.
Markowitz, John S.
and
Caley, Charles F.
2001.
New onset diabetes and atypical antipsychotics.
European Neuropsychopharmacology,
Vol. 11,
Issue. 1,
p.
25.
Kato, Martha M
and
Goodnick, Paul J
2001.
Antipsychotic medication: effects on regulation of glucose and lipids.
Expert Opinion on Pharmacotherapy,
Vol. 2,
Issue. 10,
p.
1571.
Bouchard, Roch Hugo
Demers, Marie-France
Simoneau, Isabelle
Alméras, Natalie
Villeneuve, Julie
Mottard, Jean-Pierre
Cadrin, Camille
Lemieux, Isabelle
and
Després, Jean-Pierre
2001.
Atypical Antipsychotics and Cardiovascular Risk in Schizophrenic Patients.
Journal of Clinical Psychopharmacology,
Vol. 21,
Issue. 1,
p.
110.
Haupt, Dan W
and
Newcomer, John W
2002.
Abnormalities in glucose regulation associated with mental illness and treatment.
Journal of Psychosomatic Research,
Vol. 53,
Issue. 4,
p.
925.
Henderson, David C.
2002.
Atypical Antipsychotic???Induced Diabetes Mellitus.
CNS Drugs,
Vol. 16,
Issue. 2,
p.
77.
Henderson, David C.
2002.
Diabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agents.
Current Diabetes Reports,
Vol. 2,
Issue. 2,
p.
135.
Henderson, David C.
and
Ettinger, Elissa R.
2002.
Glucose Metabolism in the Brain.
Vol. 51,
Issue. ,
p.
481.
Clark, Clifford
and
Burge, Mark R.
2003.
Diabetes Mellitus Associated with Atypical Anti-Psychotic Medications.
Diabetes Technology & Therapeutics,
Vol. 5,
Issue. 4,
p.
669.
Lafayette, Jennifer M.
Pirl, William F.
and
Henderson, David C.
2003.
Low-Dose Clozapine and Diabetic Ketoacidosis.
Psychosomatics,
Vol. 44,
Issue. 3,
p.
249.
Gianfrancesco, Frank
Grogg, Amy
Mahmoud, Ramy
Wang, Ruey-Hua
and
Meletiche, Dennis
2003.
Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders.
Clinical Therapeutics,
Vol. 25,
Issue. 4,
p.
1150.
Gianfrancesco, Frank
White, Richard
Wang, Ruey-hua
and
Nasrallah, Henry A.
2003.
Antipsychotic-Induced Type 2 Diabetes: Evidence From a Large Health Plan Database.
Journal of Clinical Psychopharmacology,
Vol. 23,
Issue. 4,
p.
328.
Gupta, Sanjay
Steinmeyer, Charles
Frank, Bradford
Madhusoodanan, S.
Lockwood, Kari
Lentz, Barbara
and
Keller, Peggy
2003.
Hyperglycemia and Hypertriglyceridemia in Real World Patients on Antipsychotic Therapy.
American Journal of Therapeutics,
Vol. 10,
Issue. 5,
p.
348.
Fuller, Matthew A.
Shermock, Kenneth M.
Secic, Michelle
and
Grogg, Amy L.
2003.
Comparative Study of the Development of Diabetes Mellitus in Patients Taking Risperidone and Olanzapine.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 23,
Issue. 8,
p.
1037.
Schwenkreis, Peter
and
Assion, Hans-jörg
2004.
Atypical antipsychotics and diabetes mellitus.
The World Journal of Biological Psychiatry,
Vol. 5,
Issue. 2,
p.
73.
Dinan, Timothy G.
2004.
Introduction.
British Journal of Psychiatry,
Vol. 184,
Issue. S47,
p.
s53.
Melkersson, Kristina
and
Dahl, Marja-Liisa
2004.
Adverse Metabolic Effects Associated with Atypical Antipsychotics.
Drugs,
Vol. 64,
Issue. 7,
p.
701.
eLetters
No eLetters have been published for this article.